Industries
Spatial Transcriptomics and Imaging
Spatial transcriptomics preserves the tissue context of gene expression data, enabling researchers to map molecular heterogeneity within intact tissues. Instrument companies partner with academic pathology and genomics departments to develop clinical FFPE workflows, tumor microenvironment atlases, and computational tools for spatial data interpretation.
Details
- Companies
- 10x Genomics VisiumNanostring CosMxAkoya BiosciencesLunaphore TechnologiesCurio SeekerVizgen MERSCOPEResolve BiosciencesPixel GenomicsBioInformatics SolutionsSciSTAR Cartana
- Market Size
- $1.8B
- Target Researchers
- Pathologists, genomicists, and computational biologists specializing in spatial gene expression, multiplex immunofluorescence, FISH-based in situ sequencing, tissue atlas construction, and spatial data analysis for oncology and neuroscience applications
- Use Cases
- Spatial sequencing reagent and kit supplyTissue atlas co-developmentClinical FFPE tissue analysis servicesMultiplex panel design consultingSpatial-single cell data integrationDigital pathology AI model development